Lactoserum (Dermacyd Femina®) and Prevention of Recurrence of Bacterial Vaginosis

Local, National (Brazil), Multicentric, Open, Non-Controlled, Phase IV, Study of Lactoserum (Dermacyd Femina®), in Women at Reproductive Age, to Prevent Recurrence of Bacterial Vaginosis, During Three Months, After Standard Treatment With Metronidazole.

The purpose of this study is to demonstrate if the use of Dermacyd can avoid the recurrence of bacterial vaginosis after three months of the standard treatment.

Inclusion Criteria:

• Women in reproductive age
• Confirmed cure of bacterial vaginosis after treatment with oral metronidazole.
• Vaginal bacterioscopic examination negative for candida and trichomonas.

Exclusion Criteria:

• Pregnant or breastfeeding women
• Allergy to dermacyd

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.